StonvexLoading…
StonvexStonvexStonvexCore line items from VCYT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $517.14M | $445.76M | $361.05M | $296.54M |
Operating Income | $57.78M | $16.14M | $-85.80M | $-41.08M |
Net Income | $66.35M | $24.14M | $-74.40M | $-36.56M |
EPS (Diluted) | $0.82 | $0.31 | $-1.02 | $-0.51 |
Total Assets | $1.41B | $1.30B | $1.11B | $1.16B |
Total Liabilities | $96.44M | $124.07M | $70.80M | $81.22M |
Cash & Equivalents | $362.58M | $239.09M | $216.45M | $154.25M |
Free Cash Flow OCF − CapEx | $126.63M | $63.81M | $34.26M | $-1.01M |
Shares Outstanding | 79.36M | 77.77M | 73.26M | 71.96M |